Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease

Huntington's Disease

Key Findings

We suggest that the CB(1) receptor, through G-protein alpha subtype i/o (G(i/o))-linked, ERK-dependent signal transduction, is a therapeutic target in HD.

Information and Links


Link: Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease

Year: 2010

DOI: 10.1111/j.1476-5381.2010.00773.x


Ratings

(How Ratings Work)

Huntington's Disease — 1


Possibility of efficacy for cannabis in treatment of Huntington's Disease according to the results found in this study.

Drugs Used

HU210